Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01026532 · ClinicalTrials.gov registry record
Functional Activity of Airway Eosinophils in Allergic Disease
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 31
- Enrollment target
NCT01026532 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 31 participants.
The verdict
NCT01026532 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 31 participants
- Enrollment target
Study Summary
The purpose of this study is to determine how a special white blood cell, the eosinophil, can contribute to asthma. One of the characteristics of asthma is airway inflammation. Airway inflammation in asthma may occur when an allergen is inhaled and sets up an allergic reaction in the bronchial tubes. This reaction may lead to chest tightness, cough and wheeze. To better understand the way in which the eosinophil can cause inflammation, the investigators plan to study eosinophils that move in to the lung following an allergic reaction.
Interventions
- BIOLOGICAL Segmental Allergen Challenge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2011-08-24 |
| Est. Completion | 2017-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01026532
The ClinicalTrials.gov registry entry for NCT01026532 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Segmental Allergen Challenge is the first listed.
NCT01026532 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01026532 about?
NCT01026532 is a clinical study titled "Functional Activity of Airway Eosinophils in Allergic Disease". The purpose of this study is to determine how a special white blood cell, the eosinophil, can contribute to asthma. One of the characteristics of asthma is airway inflammation. Airway inflammation in asthma may occur when an allergen is inhaled and sets up an allergic reaction in the bronchial tubes...
What is the current status of trial NCT01026532?
This trial is currently completed. The enrollment target is 31 participants. The study started on 2011-08-24. Estimated completion is 2017-03-31.
What interventions are being tested in trial NCT01026532?
The interventions under investigation include: Segmental Allergen Challenge (BIOLOGICAL).
Who is sponsoring clinical trial NCT01026532?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.